Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: CEO and Director Compensation

Cliff, Gloria and Carl need a reality slap.

We have experienced significant growth in a short period of time. Our net revenue increased from $29.0 million in fiscal year 2009 to $79.6 million, $96.5 million, $153.0 million, $208.6 million and $252.5 million in fiscal years 2010, 2011, 2012, 2013 and 2014, respectively. We may not achieve similar growth rates in future. p. 14 of 10K

Behrooz Abdi

In connection with Mr. Abdi’s appointment as President and Chief Executive Officer on October 24, 2012, we entered into an employment agreement and an executive change in control and severance agreement with Mr. Abdi. Pursuant to the employment agreement, Mr. Abdi’s annual base salary was set at $400,000 per year and he was to earn an annual performance bonus of $100,000, if bonuses were otherwise paid under our executive bonus plan for 2013. The agreement provides that Mr. Abdi will participate in the future in any other bonus or similar plan for our executive officers adopted by our Board of Directors.

Along with our other executive officers, Mr. Abdi did not receive a bonus in fiscal 2013.

See Proxy filed 7/29/13

http://ir.invensense.com/phoenix.zhtml?c=237953&p=irol-sec&secCat01Enhanced.1_rs=91&secCat01Enhanced.1_rc=10#8935659

Share
New Message
Please login to post a reply